234 related articles for article (PubMed ID: 8424935)
1. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
Yamamoto K; Sugiyama H; Kawanishi S
Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
[TBL] [Abstract][Full Text] [Related]
2. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
3. Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.
Sugiyama H; Lian C; Isomura M; Saito I; Wang AH
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14405-10. PubMed ID: 8962064
[TBL] [Abstract][Full Text] [Related]
4. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
Yamamoto K; Kawanishi S
Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
[TBL] [Abstract][Full Text] [Related]
5. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
Sugiyama H; Lam CK; Hosoda M; Saito I
Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
[TBL] [Abstract][Full Text] [Related]
6. Distamycin A enhances the cytotoxicity of duocarmycin A and suppresses duocarmycin A-induced apoptosis in human lung carcinoma cells.
Hirota M; Fujiwara T; Mineshita S; Sugiyama H; Teraoka H
Int J Biochem Cell Biol; 2007; 39(5):988-96. PubMed ID: 17321782
[TBL] [Abstract][Full Text] [Related]
7. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
Ozeki Y; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
[TBL] [Abstract][Full Text] [Related]
8. Chemistry of drug-induced DNA lesions.
Saito I
Toxicol Lett; 1993 Apr; 67(1-3):3-15. PubMed ID: 8451767
[TBL] [Abstract][Full Text] [Related]
9. Sequence-selective guanine reactivity by duocarmycin A.
Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the covalent duocarmycin A-DNA duplex complex.
Lin CH; Patel DJ
J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
[TBL] [Abstract][Full Text] [Related]
13. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
14. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
15. N-(2-chloroethyl)-N-nitrosoureas covalently bound to nonionic and monocationic lexitropsin dipeptides. Synthesis, DNA affinity binding characteristics, and reactions with 32P-end-labeled DNA.
Church KM; Wurdeman RL; Zhang Y; Chen FX; Gold B
Biochemistry; 1990 Jul; 29(29):6827-38. PubMed ID: 2168742
[TBL] [Abstract][Full Text] [Related]
16. The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation.
Wyatt MD; Lee M; Hartley JA
Nucleic Acids Res; 1997 Jun; 25(12):2359-64. PubMed ID: 9171086
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative analysis of DNA methylation at N3-adenine by N-methyl-N-nitrosourea.
Kelly JD; Shah D; Chen FX; Wurdeman R; Gold B
Chem Res Toxicol; 1998 Dec; 11(12):1481-6. PubMed ID: 9860491
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
Boger DL; Johnson DS; Yun W; Tarby CM
Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
[TBL] [Abstract][Full Text] [Related]
19. Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Ginsburg H; Nissani E; Krugliak M; Williamson DH
Mol Biochem Parasitol; 1993 Mar; 58(1):7-15. PubMed ID: 7681547
[TBL] [Abstract][Full Text] [Related]
20. Interaction of lambda cro repressor with synthetic operator OR3 studied by competition binding with minor groove binders.
Gursky GV; Surovaya AN; Kurochkin AV; Chernov BK; Volkov SK; Kirpichnikov MP
J Biomol Struct Dyn; 1992 Aug; 10(1):15-33. PubMed ID: 1329842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]